Arrowstreet Capital’s Medidata Solutions, Inc. MDSO Stock Holding History

Arrowstreet Capital’s Portfolio MDSO Stock Details MDSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-55,798	Closed	-$4.09M	–	1900
2019 Q1	$4.09M	Buy	55,798 +52,598	+1,644%	+$3.8M	0.01%	864
2018 Q4	$216K	Buy	+3,200	New	+$226K	﹤0.01%	1240
2016 Q4	–	Sell	-7,200	Closed	-$401K	–	2798
2016 Q3	$401K	Buy	+7,200	New	+$382K	﹤0.01%	1301
2016 Q1	–	Sell	-14,100	Closed	-$695K	–	1651
2015 Q4	$695K	Sell	14,100 -12,400	-47%	-$546K	﹤0.01%	1074
2015 Q3	$1.12M	Buy	26,500 +19,800	+296%	+$1.01M	0.01%	897
2015 Q2	$364K	Buy	+6,700	New	+$360K	﹤0.01%	1031

Other funds holding MDSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Arrowstreet Capital's MDSO Position: Q2 2019 in Review

Arrowstreet Capital sold out of Medidata Solutions, Inc. (MDSO) in Q2 2019, closing a stake of 55,798 shares — an estimated $4.09M sold.

Arrowstreet Capital first reported a position in MDSO in Q2 2015 and held it in 6 quarters. The position peaked at $4.09M in Q1 2019. 302 funds tracked by Wall St. Rank hold MDSO as of Q2 2019.

Arrowstreet Capital reported no remaining Medidata Solutions, Inc. position as of Q2 2019 after selling out during the quarter.
Arrowstreet Capital sold 55,798 Medidata Solutions, Inc. shares in Q2 2019, an estimated $4.09M.
Arrowstreet Capital first reported a position in Medidata Solutions, Inc. in Q2 2015 and held it in 6 quarters.
Arrowstreet Capital's Medidata Solutions, Inc. position peaked at $4.09M in Q1 2019.
302 funds tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q2 2019.

Based on Arrowstreet Capital's 13F filing for Q2 2019, filed 14 Aug 2019.